[Multivariate analysis of imatinib resistance-related factors during the treatment of chronic myeloid leukemia].

MLA

Zhou, Min, et al. “[Multivariate Analysis of Imatinib Resistance-Related Factors during the Treatment of Chronic Myeloid Leukemia].” Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, vol. 34, no. 5, May 2013, pp. 395–98. EBSCOhost, https://doi.org/10.3760/cma.j.issn.0253-2727.2013.05.004.

APA

Zhou, M., Qiu, H., He, G., Xu, Y., Cen, J., Pan, J., Chen, S., Sun, A., Zhang, R., & Wu, D. (2013). [Multivariate analysis of imatinib resistance-related factors during the treatment of chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 34(5), 395–398. https://doi.org/10.3760/cma.j.issn.0253-2727.2013.05.004

Chicago

Zhou, Min, Hui-ying Qiu, Guang-sheng He, Yang Xu, Jian-nong Cen, Jin-lan Pan, Su-ning Chen, Ai-ning Sun, Ri Zhang, and De-pei Wu. 2013. “[Multivariate Analysis of Imatinib Resistance-Related Factors during the Treatment of Chronic Myeloid Leukemia].” Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi 34 (5): 395–98. doi:10.3760/cma.j.issn.0253-2727.2013.05.004.